rs886041691

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong

The NM_020822.3(KCNT1):​c.1546A>G​(p.Met516Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KCNT1
NM_020822.3 missense

Scores

2
4
13

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 3.55

Publications

12 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.772
PP5
Variant 9-135769982-A-G is Pathogenic according to our data. Variant chr9-135769982-A-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 280499.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNT1NM_020822.3 linkc.1546A>G p.Met516Val missense_variant Exon 16 of 31 ENST00000371757.7 NP_065873.2 Q5JUK3-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNT1ENST00000371757.7 linkc.1546A>G p.Met516Val missense_variant Exon 16 of 31 1 NM_020822.3 ENSP00000360822.2 Q5JUK3-3

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1404376
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
693328
African (AFR)
AF:
0.00
AC:
0
AN:
31898
American (AMR)
AF:
0.00
AC:
0
AN:
36878
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25194
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36238
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79542
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48776
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082366
Other (OTH)
AF:
0.00
AC:
0
AN:
58174
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.000130
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 14 Pathogenic:2
Aug 07, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was identified as de novo (maternity and paternity confirmed). -

-
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Pathogenic:1
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 516 of the KCNT1 protein (p.Met516Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with KCNT1-related conditions (PMID: 26784557). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 280499). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNT1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects KCNT1 function (PMID: 26784557). For these reasons, this variant has been classified as Pathogenic. -

Malignant migrating partial seizures of infancy Pathogenic:1
Nov 16, 2016
Neurogenetics Laboratory - MEYER, AOU Meyer
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Apr 09, 2021
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26784557, 27064559, 30182418, 31532509, 31872048) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.084
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.25
.;.;.;.;.;.;.;.;T;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.26
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Pathogenic
0.98
D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.030
D
MetaRNN
Pathogenic
0.77
D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.7
.;.;.;.;.;.;.;.;L;.
PhyloP100
3.6
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-2.2
.;.;N;N;.;.;.;.;N;N
REVEL
Benign
0.18
Sift
Uncertain
0.0040
.;.;D;D;.;.;.;.;D;D
Sift4G
Uncertain
0.0090
D;D;D;D;D;D;D;D;D;D
Polyphen
0.013
.;.;.;.;.;.;.;.;B;.
Vest4
0.89
MutPred
0.68
.;.;.;.;.;.;Gain of ubiquitination at K494 (P = 0.078);Gain of ubiquitination at K494 (P = 0.078);Gain of ubiquitination at K494 (P = 0.078);Gain of ubiquitination at K494 (P = 0.078);
MVP
0.59
MPC
0.68
ClinPred
0.76
D
GERP RS
2.2
Varity_R
0.43
gMVP
0.85
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886041691; hg19: chr9-138661828; API